Jonathan P H Fisher

6PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2026
Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies.

|Aug 29, 2025
Phenoscaping Reveals Multimodal γδ T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated Immunomodulation.

Callum Baird Nattress, Rhianna O'Sullivan, Daniel Fowler

|Aug 05, 2025
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function.

Marta Barisa, Henrike P Muller, Elisa Zappa

|May 29, 2024
Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma.

Daniel Fowler, Marta Barisa, Alba Southern

|Dec 01, 2022
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells.

Ilaria M Michelozzi, Eduardo Gomez-Castaneda, Ruben V C Pohle

|Sep 12, 2019
Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.

Jonathan Fisher, Roshan Sharma, Dilu Wisidagamage Don

Pageof 1

Frequent Collaborators

5 joint publications

Marta Barisa

4 joint publications

John Anderson

3 joint publications

Christopher J Tape

2 joint publications

Kerry Chester